Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ndovu9
    Junior Member
    • Jul 2013
    • 3

    RNASeq TPM vs. FPKM - What's the point if differential expression tools use counts?

    I am confused about RNASeq quantification and normalization. There seems to be debate on the correct way to normalize RNASeq data, and the creator of RPKM/FPKM now advocates using TPM instead (http://liorpachter.wordpress.com/201...t/#comment-246). However, Cuffdiff seems to be the only differential expression tool that uses normalized expression values (I may be wrong here), but it is not clear to me exactly how Cuffdiff works. In contrast, count based differential expression methods (DESeq, edgeR, EBSeq and others) try to use counts and do not focus of TPM vs. FPKM issues of normalization.

    My question is, what is the point of RNASeq normalization if the majority of differential expression methods do not even use these normalization methods? Is the normalization for comparison of the general "expression level" of a single gene across multiple samples, or possibly to understand whether a gene is highly or lowly expressed relative to other genes within a sample? Alternatively, should differential expression tools attempt to use normalized values?
  • samanta
    Senior Member
    • Feb 2010
    • 108

    #2
    Our blog has some discussion going on between Lior Pachter and Istvan that you may find helpful.

    http://homolog.us

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM
    • GATTACAT
      Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
      by GATTACAT
      Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
      07-01-2026, 11:43 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    33 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-07-2026, 11:05 AM
    0 responses
    34 views
    0 reactions
    Last Post SEQadmin2  
    Working...